Published in Infect Immun on October 16, 2006
Protective immune mechanisms in helminth infection. Nat Rev Immunol (2007) 5.66
Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol (2010) 2.26
Helminth infections and host immune regulation. Clin Microbiol Rev (2012) 2.02
pH of drinking water influences the composition of gut microbiome and type 1 diabetes incidence. Diabetes (2013) 1.70
Helminth-host immunological interactions: prevention and control of immune-mediated diseases. Ann N Y Acad Sci (2012) 1.47
Anti-FcεR1 antibody injections activate basophils and mast cells and delay Type 1 diabetes onset in NOD mice. Clin Immunol (2011) 1.31
Inhibition of type 1 diabetes in filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3+ regulatory T cells. Immunology (2008) 1.27
Review series on helminths, immune modulation and the hygiene hypothesis: how might infection modulate the onset of type 1 diabetes? Immunology (2009) 1.22
Proteomic analysis of secretory products from the model gastrointestinal nematode Heligmosomoides polygyrus reveals dominance of venom allergen-like (VAL) proteins. J Proteomics (2011) 1.16
An update on the use of NOD mice to study autoimmune (Type 1) diabetes. Expert Rev Clin Immunol (2010) 1.13
Advances in the pathogenesis and treatment of IBD. Clin Immunol (2009) 1.10
Systemic impact of intestinal helminth infections. Mucosal Immunol (2014) 1.08
Helminth infection can reduce insulitis and type 1 diabetes through CD25- and IL-10-independent mechanisms. Infect Immun (2009) 1.07
Immunity to the model intestinal helminth parasite Heligmosomoides polygyrus. Semin Immunopathol (2012) 1.06
Coinfection with the intestinal nematode Heligmosomoides polygyrus markedly reduces hepatic egg-induced immunopathology and proinflammatory cytokines in mouse models of severe schistosomiasis. Infect Immun (2008) 1.02
Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-β. J Immunol (2011) 1.02
The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease. Clin Exp Immunol (2009) 1.01
Gastrointestinal nematode infection exacerbates malaria-induced liver pathology. J Immunol (2009) 1.01
Suppression of type 2 immunity and allergic airway inflammation by secreted products of the helminth Heligmosomoides polygyrus. Eur J Immunol (2012) 1.00
Chronic Trichuris muris Infection Decreases Diversity of the Intestinal Microbiota and Concomitantly Increases the Abundance of Lactobacilli. PLoS One (2015) 1.00
Helminths in the hygiene hypothesis: sooner or later? Clin Exp Immunol (2014) 0.99
Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients. J Clin Invest (2008) 0.99
Protection against or triggering of Type 1 diabetes? Different roles for viral infections. Expert Rev Clin Immunol (2011) 0.99
Helminth infections decrease host susceptibility to immune-mediated diseases. J Immunol (2014) 0.93
Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications. BMC Med (2015) 0.93
Taenia crassiceps infection attenuates multiple low-dose streptozotocin-induced diabetes. J Biomed Biotechnol (2010) 0.92
Infection of non-encapsulated species of Trichinella ameliorates experimental autoimmune encephalomyelitis involving suppression of Th17 and Th1 response. Parasitol Res (2010) 0.90
Excretory/secretory products from Trichinella spiralis adult worms ameliorate DSS-induced colitis in mice. PLoS One (2014) 0.89
Decreased prevalence of lymphatic filariasis among subjects with type-1 diabetes. Am J Trop Med Hyg (2010) 0.88
The battle against immunopathology: infectious tolerance mediated by regulatory T cells. Cell Mol Life Sci (2011) 0.87
Helminth secretome database (HSD): a collection of helminth excretory/secretory proteins predicted from expressed sequence tags (ESTs). BMC Genomics (2012) 0.86
Alternatively activated macrophages in types 1 and 2 diabetes. Mediators Inflamm (2012) 0.86
Helminths: Immunoregulation and Inflammatory Diseases-Which Side Are Trichinella spp. and Toxocara spp. on? J Parasitol Res (2013) 0.85
Evolutionary biology and anthropology suggest biome reconstitution as a necessary approach toward dealing with immune disorders. Evol Med Public Health (2013) 0.85
Immunomodulation with microbial vaccines to prevent type 1 diabetes mellitus. Nat Rev Endocrinol (2010) 0.85
Regulation of type 1 diabetes, tuberculosis, and asthma by parasites. J Mol Med (Berl) (2009) 0.85
Heligmosomoides polygyrus abrogates antigen-specific gut injury in a murine model of inflammatory bowel disease. Inflamm Bowel Dis (2012) 0.85
Immunoregulation by Taenia crassiceps and its antigens. Biomed Res Int (2012) 0.84
Modulation of dendritic cell function and immune response by cysteine protease inhibitor from murine nematode parasite Heligmosomoides polygyrus. Immunology (2013) 0.84
Secreted proteins from the helminth Fasciola hepatica inhibit the initiation of autoreactive T cell responses and prevent diabetes in the NOD mouse. PLoS One (2014) 0.83
Autoimmunity and inflammation: murine models and translational studies. Mamm Genome (2011) 0.82
A multivalent vaccine for type 1 diabetes skews T cell subsets to Th2 phenotype in NOD mice. Immunol Res (2011) 0.82
Lessons from helminth infections: ES-62 highlights new interventional approaches in rheumatoid arthritis. Clin Exp Immunol (2014) 0.81
Cultivation of Heligmosomoides polygyrus: an immunomodulatory nematode parasite and its secreted products. J Vis Exp (2015) 0.81
Role of macrophages in the altered epithelial function during a type 2 immune response induced by enteric nematode infection. PLoS One (2014) 0.81
Trichinella spiralis excretory-secretory products protect against polymicrobial sepsis by suppressing MyD88 via mannose receptor. Biomed Res Int (2014) 0.80
Malaria endemicity and co-infection with tissue-dwelling parasites in Sub-Saharan Africa: a review. Infect Dis Poverty (2015) 0.78
Helminth infection and type 1 diabetes. Rev Diabet Stud (2012) 0.76
Filarial Abundant Larval Transcript Protein ALT-2: An Immunomodulatory Therapeutic Agent for Type 1 Diabetes. Indian J Clin Biochem (2016) 0.75
Secretory Products of Trichinella spiralis Muscle Larvae and Immunomodulation: Implication for Autoimmune Diseases, Allergies, and Malignancies. J Immunol Res (2015) 0.75
Anti-Arthritic Activity of Schistosoma mansoni and Trichinella spiralis Derived-Antigens in Adjuvant Arthritis in Rats: Role of FOXP3+ Treg Cells. PLoS One (2016) 0.75
Nonencapsulated Trichinella pseudospiralis Infection Impairs Follicular Helper T Cell Differentiation with Subclass-Selective Decreases in Antibody Responses. Infect Immun (2016) 0.75
A life without worms. Trans R Soc Trop Med Hyg (2017) 0.75
Helminth Immunomodulation in Autoimmune Disease. Front Immunol (2017) 0.75
Therapeutic potential of helminths in autoimmune diseases: helminth-derived immune-regulators and immune balance. Parasitol Res (2017) 0.75
The NOD mouse: a model of immune dysregulation. Annu Rev Immunol (2005) 6.71
Allergy, parasites, and the hygiene hypothesis. Science (2002) 5.01
Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models. Annu Rev Immunol (1997) 4.22
Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat Med (2000) 4.09
Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J Exp Med (2005) 3.63
Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol (2003) 3.40
alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J Exp Med (1998) 3.34
The rise of childhood type 1 diabetes in the 20th century. Diabetes (2002) 2.77
Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci U S A (1993) 2.65
Immunological modulation and evasion by helminth parasites in human populations. Nature (1993) 2.62
Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guérin (BCG) vaccination. Clin Exp Immunol (2001) 2.43
Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol (2002) 2.28
Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes (1990) 2.04
Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol (1994) 2.03
Intestinal nematode parasites, cytokines and effector mechanisms. Int J Parasitol (1998) 1.75
Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol (1999) 1.71
Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J Autoimmun (1991) 1.71
Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol (2003) 1.60
Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient. J Clin Invest (2004) 1.49
IL-4-regulated enteropathy in an intestinal nematode infection. Eur J Immunol (1998) 1.46
Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice. J Clin Invest (1989) 1.38
Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int Immunol (2003) 1.34
Systemic dissemination and persistence of Th2 and type 2 cells in response to infection with a strictly enteric nematode parasite. J Immunol (2005) 1.33
Functional flexibility in T cells: independent regulation of CD4+ T cell proliferation and effector function in vivo. Immunity (2000) 1.30
Cutting edge: interactions through the IL-10 receptor regulate autoimmune diabetes. J Immunol (2001) 1.13
Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. Diabetologia (1991) 1.13
Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Res Clin Pract (1990) 1.13
Immunopathology of intestinal helminth infection. Parasite Immunol (2000) 1.11
Infection and autoimmunity: are we winning the war, only to lose the peace? Trends Parasitol (2004) 1.08
Interleukin-10 limits local and body cavity inflammation during infection with muscle-stage Trichinella spiralis. Infect Immun (2004) 1.04
Inhibition of diabetes in BB rats by virus infection. J Clin Invest (1988) 1.02
Peripheral generation and function of CD4+CD25+ regulatory T cells. Curr Top Microbiol Immunol (2005) 1.02
Trichinella spiralis: delayed rejection in mice concurrently infected with Nematospiroides dubius. Exp Parasitol (1978) 0.98
Salmonella typhimurium infection in nonobese diabetic mice generates immunomodulatory dendritic cells able to prevent type 1 diabetes. J Immunol (2006) 0.96
CD4+ and CD8+ T lymphocytes: clarification of their pathogenic roles in diabetes in the NOD mouse. Res Immunol (1997) 0.96
Salmonella typhimurium infection halts development of type 1 diabetes in NOD mice. Eur J Immunol (2004) 0.94
Is there a common mechanism of gastrointestinal nematode expulsion? Parasite Immunol (2003) 0.92
Mechanisms of Mycobacterium avium-induced resistance against insulin-dependent diabetes mellitus (IDDM) in non-obese diabetic (NOD) mice: role of Fas and Th1 cells. Clin Exp Immunol (1999) 0.90
Interaction of Nematospiroides dubius and influenza virus in mice. Exp Parasitol (1972) 0.90
Contrasting effects of acute and chronic gastro-intestinal helminth infections on a heterologous immune response in a transgenic adoptive transfer model. Int J Parasitol (2005) 0.86
Paradoxical antidiabetogenic effect of gamma-interferon in DP-BB rats. Diabetes (1998) 0.86
The impact of infection on the incidence of autoimmune disease. Curr Top Med Chem (2004) 0.82
MAdCAM-1 is needed for diabetes development mediated by the T cell clone, BDC-2.5. Immunology (2005) 0.82
Investigating the impact of helminth products on immune responsiveness using a TCR transgenic adoptive transfer system. J Immunol (2003) 0.81
Effect of MHC transgene expression on spontaneous insulin autoantibody class switch in nonobese diabetic mice. Diabetes (1997) 0.80
Gamma interferon prevents diabetes in the BB rat. Clin Diagn Lab Immunol (1997) 0.78
Modulation of the pathologic and apoptotic changes of experimental toxoplasmosis by concomitant infection with Trichinella spiralis. J Egypt Soc Parasitol (2000) 0.77
The effect of the expulsion phase of Trichinella spiralis on Hymenolepis diminuta infection in rats. Parasitology (1979) 0.77
Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest (2009) 4.74
High mobility of vesicles supports continuous exocytosis at a ribbon synapse. Curr Biol (2004) 2.28
Validated germline-competent embryonic stem cell lines from nonobese diabetic mice. Nat Med (2009) 2.26
Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol (2010) 2.26
Paneth cells as a site of origin for intestinal inflammation. Nature (2013) 2.09
Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst (2007) 2.07
Bulk membrane retrieval in the synaptic terminal of retinal bipolar cells. J Neurosci (2003) 1.99
Interplay of parasite-driven immune responses and autoimmunity. Trends Parasitol (2007) 1.80
Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells. J Immunol (2006) 1.75
ER stress transcription factor Xbp1 suppresses intestinal tumorigenesis and directs intestinal stem cells. J Exp Med (2013) 1.70
Type 1 diabetes: translating mechanistic observations into effective clinical outcomes. Nat Rev Immunol (2013) 1.65
Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol (2003) 1.60
Endogenous calcium buffers regulate fast exocytosis in the synaptic terminal of retinal bipolar cells. Neuron (2002) 1.45
A worm's eye view of the immune system: consequences for evolution of human autoimmune disease. Nat Rev Immunol (2005) 1.41
Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells. Immunology (2007) 1.35
Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice. Eur J Immunol (2009) 1.29
Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide. Crit Rev Immunol (2008) 1.19
Infection and autoimmunity: are we winning the war, only to lose the peace? Trends Parasitol (2004) 1.08
CD4 T cells and their antigens in the pathogenesis of autoimmune diabetes. Curr Opin Immunol (2011) 1.08
Ornithine decarboxylase and ribosomal RNA synthesis during the stimulation of lymphocytes by phytohaemagglutinin. FEBS Lett (1971) 1.04
Type 1 diabetes development requires both CD4+ and CD8+ T cells and can be reversed by non-depleting antibodies targeting both T cell populations. Rev Diabet Stud (2009) 1.03
Patients with chronic pancreatitis have islet progenitor cells in their ducts, but reversal of overt diabetes in NOD mice by anti-CD3 shows no evidence for islet regeneration. Diabetes (2007) 1.03
AIRE's CARD revealed, a new structure for central tolerance provokes transcriptional plasticity. J Biol Chem (2007) 1.03
Exocytosis at the ribbon synapse of retinal bipolar cells studied in patches of presynaptic membrane. J Neurosci (2003) 1.01
Immune mechanisms in type 1 diabetes. Trends Immunol (2013) 0.98
An early age-related increase in the frequency of CD4+ Foxp3+ cells in BDC2.5NOD mice. Immunology (2007) 0.96
Salmonella typhimurium infection in nonobese diabetic mice generates immunomodulatory dendritic cells able to prevent type 1 diabetes. J Immunol (2006) 0.96
Cutting Edge: Regulator of G protein signaling-1 selectively regulates gut T cell trafficking and colitic potential. J Immunol (2011) 0.96
Epigenetic changes at Il12rb2 and Tbx21 in relation to plasticity behavior of Th17 cells. J Immunol (2011) 0.96
Immune modulation by Schistosoma mansoni antigens in NOD mice: effects on both innate and adaptive immune systems. J Biomed Biotechnol (2010) 0.95
Salmonella typhimurium infection halts development of type 1 diabetes in NOD mice. Eur J Immunol (2004) 0.94
The S. mansoni glycoprotein ω-1 induces Foxp3 expression in NOD mouse CD4⁺ T cells. Eur J Immunol (2011) 0.94
Roles for TGF-beta and programmed cell death 1 ligand 1 in regulatory T cell expansion and diabetes suppression by zymosan in nonobese diabetic mice. J Immunol (2010) 0.91
Inflammation and type one diabetes. Int Immunol (2012) 0.91
Murine gammaherpesvirus-68 infection alters self-antigen presentation and type 1 diabetes onset in NOD mice. J Immunol (2007) 0.90
Autoimmune thyroid disease induced by thyroglobulin and lipopolysaccharide is inhibited by soluble TNF receptor type I. Eur J Immunol (2002) 0.90
Loss of invariant chain protects nonobese diabetic mice against type 1 diabetes. J Immunol (2006) 0.89
Modulation of a heterologous immune response by the products of Ascaris suum. Infect Immun (2002) 0.89
Vaccine against autoimmune disease: can helminths or their products provide a therapy? Curr Opin Immunol (2013) 0.88
Cross-reactive mycobacterial and self hsp60 epitope recognition in I-A(g7) expressing NOD, NOD-asp and Biozzi AB/H mice. J Autoimmun (2002) 0.88
The nonconventional MHC class II molecule DM governs diabetes susceptibility in NOD mice. PLoS One (2013) 0.87
Effect of inducible costimulator blockade on the pathological and protective immune responses induced by the gastrointestinal helminth Trichinella spiralis. Eur J Immunol (2004) 0.85
Butyrophilin Btn2a2 inhibits TCR activation and phosphatidylinositol 3-kinase/Akt pathway signaling and induces Foxp3 expression in T lymphocytes. J Immunol (2013) 0.84
Accelerated turnover of MHC class II molecules in nonobese diabetic mice is developmentally and environmentally regulated in vivo and dispensable for autoimmunity. J Immunol (2013) 0.83
Perturbation of naive TCR transgenic T cell functional responses and upstream activation events by anti-CD4 monoclonal antibodies. Eur J Immunol (2002) 0.83
The impact of infection on the incidence of autoimmune disease. Curr Top Med Chem (2004) 0.82
Overcoming self-destruction in the pancreas. Curr Opin Biotechnol (2009) 0.82
MAdCAM-1 is needed for diabetes development mediated by the T cell clone, BDC-2.5. Immunology (2005) 0.82
Autoimmunity and inflammation: murine models and translational studies. Mamm Genome (2011) 0.82
Helminth mediated modulation of Type 1 diabetes (T1D). Int J Parasitol (2013) 0.81
Investigating the impact of helminth products on immune responsiveness using a TCR transgenic adoptive transfer system. J Immunol (2003) 0.81
OX40 interactions in gastrointestinal nematode infection. Immunology (2006) 0.81
IL-18 binding protein fusion construct delays the development of diabetes in adoptive transfer and cyclophosphamide-induced diabetes in NOD mouse. Clin Immunol (2005) 0.81
Both central and peripheral tolerance mechanisms play roles in diabetes prevention in NOD-E transgenic mice. Autoimmunity (2008) 0.80
Can infections protect against autoimmunity? Curr Opin Rheumatol (2009) 0.80
Comment on: Tritt et al. (2007) Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes: Diabetes 57:113-123, 2007. Diabetes (2008) 0.80
Neither interleukin-4 receptor alpha expression on CD4+ T cells, or macrophages and neutrophils is required for protective immunity to Trichinella spiralis. Immunology (2008) 0.80
The role of regulatory T cell defects in type I diabetes and the potential of these cells for therapy. Rev Diabet Stud (2005) 0.79
Mast cells and vascular diseases. Pharmacol Ther (2013) 0.79
Non-depleting anti-CD4 antibody not only prevents onset but resolves sialadenitis in NOD mice. Autoimmunity (2004) 0.79
Infectious triggers protect from autoimmunity. Semin Immunol (2011) 0.79
Importance of TLR2 in the direct response of T lymphocytes to Schistosoma mansoni antigens. Eur J Immunol (2010) 0.79
Death in the AIRE. Trends Immunol (2008) 0.79
Can helminth antigens be exploited therapeutically to downregulate pathological Th1 responses? Curr Opin Investig Drugs (2004) 0.78
Harnessing CD8(+) regulatory T cells: therapy for type 1 diabetes? Immunity (2010) 0.78
Endogenous interleukin-18 is involved in immunity to Leishmania donovani but its absence does not adversely influence the therapeutic activity of sodium stibogluconate. Immunology (2006) 0.78
Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice. Transplantation (2002) 0.78
Genetic analysis of type 1 diabetes: embryonic stem cells as new tools to unlock biological mechanisms in type 1 diabetes. Rev Diabet Stud (2012) 0.78
Tumour necrosis factor-alpha is a fundamental cytokine in autoimmune thyroid disease induced by thyroglobulin and lipopolysaccharide in interleukin-12 p40 deficient C57BL/6 mice. Immunology (2003) 0.77
An islet-homing NOD CD8+ cytotoxic T cell clone recognizes GAD65 and causes insulitis. J Autoimmun (2003) 0.77
PD-L1 blockade overrides Salmonella typhimurium-mediated diabetes prevention in NOD mice: no role for Tregs. Eur J Immunol (2011) 0.76
Identifying potential predictors of traumatic reactions to psychotic episodes. Br J Clin Psychol (2006) 0.76
Developing positive relationships with voices: a preliminary Grounded Theory. Int J Soc Psychiatry (2010) 0.76
Regulation unmasked by activation. Nat Immunol (2013) 0.75
OdDHL inhibits T cell subset differentiation and delays diabetes onset in NOD mice. Clin Vaccine Immunol (2011) 0.75
A metabolomics and lipidomics study of mouse models of type 1 diabetes highlights divergent metabolism in purine and tryptophan metabolism prior to disease on-set. J Proteome Res (2017) 0.75
The 1st International standard for transforming growth factor-β3 (TGF-β3). J Immunol Methods (2012) 0.75
Characterisation of CD8 monoclonal antibody-induced protection from diabetes in NOD mice. Autoimmunity (2005) 0.75
Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study. Inflamm Bowel Dis (2017) 0.75
Autoimmunity: The genes and phenotypes of autoimmunity. Curr Opin Immunol (2004) 0.75